Each patient has an individualized level of risk, making the choice of treatment different for everyone. Part of the decision involves understanding the likelihood of the cancer returning and how the patient’s condition is managed after surgery.
Before the Colon Recurrence Score test, doctors could only base their recommendations on a few tumor features including margin width, size, and grade. The Colon Recurrence Score test provides information about the tumor that traditional methods can’t offer, including additional information about the chance of the cancer returning and spreading.
Understanding the Colon Recurrence Score results
Colon Recurrence Score results appear in a report that gets sent to the doctor. The report provides individualized result as a number between 0-100. A low score means there is a lower chance that the cancer will return, and a high score means there is a higher chance for a recurrence.
Distribution of Recurrence Score Results (0-100)
|A lower Recurrence Score result means: the cancer is less likely to come back||A higher Recurrence Score result means: the cancer is more likely to come back|
This information can be used to help plan the patient’s treatment options. It’s important to understand that a low Recurrence Score result does not mean there is no chance the colon cancer will return. And, a high Recurrence Score result does not mean the colon cancer will definitely return.
For stage II patients
Patients with stage II colon cancer who have a higher Colon Recurrence Score (indicating a higher risk) may benefit more from chemotherapy than those who have a lower score.
For stage III A/B patients
Patients with stage III A/B colon cancer who have a lower Colon Recurrence Score may benefit less from certain drugs added to chemotherapy than those who have a higher score.
For more information click here.
Genomic Health, Inc. (now trading as "Exact Sciences")
Oncotype DX Breast Recurrence Score, Oncotype DX and Recurrence Score are registered trademarks of Genomic Health, Inc.
Exact Sciences is a trademark or registered trademark of Exact Sciences Corporation. ©2020 Genomic Health, Inc. All rights reserved.